Since splice variants play an important role in cellular functioning and splicing factor mutations have been reported in myeloid tumors including AML [8, 34], the current study focuses on the characterization of NPM1 splice variants expression as well as its impact in AML patients. This evidence concerns the gene NPM1 and acute myeloid leukemia.